| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 38.76 | -0.73 (-1.85%) | 28.26 - 42.40 | 556.8 thousand (Below Avg) |
Market data as of 4:06PM 06/19/13. Quotes are delayed by at least 15 min.
| Open | 39.48 |
|---|---|
| Previous Close | 39.49 |
| Day's Range | 38.74 - 39.56 |
| Market Cap | 4.6B |
| Avg Volume (10 Day) | 771.5K |
| Price/Earnings (Trailing 12 Mo.) | 23.5x |
| Earnings Per Share (Trailing 12 Mo.) | 1.68 |
| Dividend Yield | 0.50 (1.29%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Pass |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Pass |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Pass |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Mindray to Acquire ZONARE Medical Systems
PR Newswire - Wednesday 06/12/2013 8:00 PM ET
Mindray Announces Appointment of Three Members to Its Executive Team
PR Newswire - Wednesday 06/12/2013 7:00 AM ET
Invitations to Investors Conferences and Annual Report Filings - Research Report on Haemonetics, Insulet, DexCom, HeartWare, and Mindray
PR Newswire - Tuesday 06/11/2013 8:00 AM ET
Mindray Announces its Recent Filing of Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
PR Newswire - Tuesday 05/21/2013 8:00 AM ET
| MR | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 17.88% | |
| Net Income Growth (1yr) | 77.04% | |
| Total Debt/Equity | 0.15 | |
| LT Debt/Equity | 0.04 | |
| Earnings Yield | 4.26% | |
| Price/Sales | 4.28 |
| Company | Last | Change |
|---|---|---|
| Cooper Companies Inc | 120.75 | -0.77% |
| DENTSPLY International Inc | 41.12 | -1.58% |
| Teleflex Inc | 77.24 | -1.78% |
| West Pharmaceutical Services Inc | 67.49 | -1.00% |
| Haemonetics Corp | 42.35 | -0.84% |
Data is delayed by at least 15 min.